3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir

R. Gagliardini, A. Bandera, M. Zaccarelli, G. Sterrantino, A. Latini, A. D’Avino, G. Lapadula, A. Antinori, R. Cauda, A. De Luca, A. Gori, S.D. Giambenedetto, M. Fabbiani

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)139-148
Number of pages10
JournalAntiviral Therapy
Volume23
Issue number2
DOIs
Publication statusPublished - 2018

Cite this

3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir. / Gagliardini, R.; Bandera, A.; Zaccarelli, M.; Sterrantino, G.; Latini, A.; D’Avino, A.; Lapadula, G.; Antinori, A.; Cauda, R.; De Luca, A.; Gori, A.; Giambenedetto, S.D.; Fabbiani, M.

In: Antiviral Therapy, Vol. 23, No. 2, 2018, p. 139-148.

Research output: Contribution to journalArticle

Gagliardini, R, Bandera, A, Zaccarelli, M, Sterrantino, G, Latini, A, D’Avino, A, Lapadula, G, Antinori, A, Cauda, R, De Luca, A, Gori, A, Giambenedetto, SD & Fabbiani, M 2018, '3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir', Antiviral Therapy, vol. 23, no. 2, pp. 139-148. https://doi.org/10.3851/IMP3188
Gagliardini, R. ; Bandera, A. ; Zaccarelli, M. ; Sterrantino, G. ; Latini, A. ; D’Avino, A. ; Lapadula, G. ; Antinori, A. ; Cauda, R. ; De Luca, A. ; Gori, A. ; Giambenedetto, S.D. ; Fabbiani, M. / 3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir. In: Antiviral Therapy. 2018 ; Vol. 23, No. 2. pp. 139-148.
@article{5e44a131e4914e278035db13df1634a5,
title = "3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir",
author = "R. Gagliardini and A. Bandera and M. Zaccarelli and G. Sterrantino and A. Latini and A. D’Avino and G. Lapadula and A. Antinori and R. Cauda and {De Luca}, A. and A. Gori and S.D. Giambenedetto and M. Fabbiani",
note = "cited By 0",
year = "2018",
doi = "10.3851/IMP3188",
language = "English",
volume = "23",
pages = "139--148",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press Ltd",
number = "2",

}

TY - JOUR

T1 - 3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir

AU - Gagliardini, R.

AU - Bandera, A.

AU - Zaccarelli, M.

AU - Sterrantino, G.

AU - Latini, A.

AU - D’Avino, A.

AU - Lapadula, G.

AU - Antinori, A.

AU - Cauda, R.

AU - De Luca, A.

AU - Gori, A.

AU - Giambenedetto, S.D.

AU - Fabbiani, M.

N1 - cited By 0

PY - 2018

Y1 - 2018

U2 - 10.3851/IMP3188

DO - 10.3851/IMP3188

M3 - Article

VL - 23

SP - 139

EP - 148

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 2

ER -